Fidelity Investments
KYTH

Fidelity Investments’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Fidelity Investments’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-3,794,236
Closed -$190M – 2874
2015
Q1 		$190M Buy
3,794,236
+395,745
+12% +$16.6M 0.02% 716
2014
Q4 		$118M Hold
3,398,491
– – 0.02% 921
2014
Q3 		$111M Hold
3,398,491
– – 0.02% 924
2014
Q2 		$130M Buy
3,398,491
+118,856
+4% +$4.15M 0.02% 859
2014
Q1 		$130M Buy
3,279,635
+1,027,637
+46% +$46M 0.02% 838
2013
Q4 		$83.9M Sell
2,251,998
-167,472
-7% -$6.95M 0.01% 1061
2013
Q3 		$111M Buy
2,419,470
+256,235
+12% +$7.66M 0.02% 898
2013
Q2 		$58.5M Buy
+2,163,235
New +$49.5M 0.01% 1176

Other funds holding KYTH

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Fidelity Investments's KYTH Position: Q2 2015 in Review

Fidelity Investments sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q2 2015, closing a stake of 3,794,236 shares — an estimated $190M sold.

Fidelity Investments first reported a position in KYTH in Q2 2013 and held it in 8 quarters. The position peaked at $190M in Q1 2015. 153 funds tracked by Wall St. Rank hold KYTH as of Q2 2015.

  • Fidelity Investments reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q2 2015 after selling out during the quarter.
  • Fidelity Investments sold 3,794,236 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q2 2015, an estimated $190M.
  • Fidelity Investments first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and held it in 8 quarters.
  • Fidelity Investments's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $190M in Q1 2015.
  • 153 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q2 2015.

Based on Fidelity Investments's 13F filing for Q2 2015, filed 13 Aug 2015.